- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-16-mer
- Ligands
- 16 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Covalent)(Non-covalent)
- 8 x IMP: INOSINIC ACID(Covalent)
IMP.3: 22 residues within 4Å:- Chain B: S.73, M.75, R.327, G.333, S.334, I.335, C.336, T.338, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.4
13 PLIP interactions:13 interactions with chain B- Hydrogen bonds: B:R.327, B:S.334, B:S.334, B:D.369, B:G.370, B:G.371, B:G.392, B:S.393, B:S.393, B:M.419, B:G.420, B:S.421, B:Q.446
IMP.7: 22 residues within 4Å:- Chain D: S.73, M.75, R.327, G.333, S.334, I.335, C.336, T.338, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.8
13 PLIP interactions:13 interactions with chain D- Hydrogen bonds: D:R.327, D:S.334, D:S.334, D:D.369, D:G.370, D:G.371, D:G.392, D:S.393, D:S.393, D:M.419, D:G.420, D:S.421, D:Q.446
IMP.11: 22 residues within 4Å:- Chain F: S.73, M.75, R.327, G.333, S.334, I.335, C.336, T.338, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.12
13 PLIP interactions:13 interactions with chain F- Hydrogen bonds: F:R.327, F:S.334, F:S.334, F:D.369, F:G.370, F:G.371, F:G.392, F:S.393, F:S.393, F:M.419, F:G.420, F:S.421, F:Q.446
IMP.15: 22 residues within 4Å:- Chain H: S.73, M.75, R.327, G.333, S.334, I.335, C.336, T.338, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.16
13 PLIP interactions:13 interactions with chain H- Hydrogen bonds: H:R.327, H:S.334, H:S.334, H:D.369, H:G.370, H:G.371, H:G.392, H:S.393, H:S.393, H:M.419, H:G.420, H:S.421, H:Q.446
IMP.19: 22 residues within 4Å:- Chain J: S.73, M.75, R.327, G.333, S.334, I.335, C.336, T.338, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.20
13 PLIP interactions:13 interactions with chain J- Hydrogen bonds: J:R.327, J:S.334, J:S.334, J:G.370, J:G.371, J:G.392, J:S.393, J:S.393, J:Y.416, J:M.419, J:G.420, J:S.421, J:Q.446
IMP.23: 22 residues within 4Å:- Chain L: S.73, M.75, R.327, G.333, S.334, I.335, C.336, T.338, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.24
13 PLIP interactions:13 interactions with chain L- Hydrogen bonds: L:R.327, L:S.334, L:S.334, L:G.370, L:G.371, L:G.392, L:S.393, L:S.393, L:Y.416, L:M.419, L:G.420, L:S.421, L:Q.446
IMP.27: 22 residues within 4Å:- Chain N: S.73, M.75, R.327, G.333, S.334, I.335, C.336, T.338, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.28
13 PLIP interactions:13 interactions with chain N- Hydrogen bonds: N:R.327, N:S.334, N:S.334, N:G.370, N:G.371, N:G.392, N:S.393, N:S.393, N:Y.416, N:M.419, N:G.420, N:S.421, N:Q.446
IMP.31: 22 residues within 4Å:- Chain P: S.73, M.75, R.327, G.333, S.334, I.335, C.336, T.338, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.32
13 PLIP interactions:13 interactions with chain P- Hydrogen bonds: P:R.327, P:S.334, P:S.334, P:G.370, P:G.371, P:G.392, P:S.393, P:S.393, P:Y.416, P:M.419, P:G.420, P:S.421, P:Q.446
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Covalent)
NAD.4: 14 residues within 4Å:- Chain B: H.258, D.279, S.280, S.281, F.287, N.308, R.327, G.329, M.330, D.369, M.419, Q.446
- Chain D: Q.474
- Ligands: IMP.3
12 PLIP interactions:10 interactions with chain B, 2 interactions with chain D- Hydrophobic interactions: B:M.330
- Hydrogen bonds: B:D.279, B:S.281, B:N.308, B:R.327, D:Q.474, D:Q.474
- Salt bridges: B:H.258
- pi-Stacking: B:F.287, B:F.287
- pi-Cation interactions: B:H.258, B:H.258
NAD.8: 14 residues within 4Å:- Chain D: H.258, D.279, S.280, S.281, F.287, N.308, R.327, G.329, M.330, D.369, M.419, Q.446
- Chain F: Q.474
- Ligands: IMP.7
12 PLIP interactions:10 interactions with chain D, 2 interactions with chain F- Hydrophobic interactions: D:M.330
- Hydrogen bonds: D:D.279, D:S.281, D:N.308, D:R.327, F:Q.474, F:Q.474
- Salt bridges: D:H.258
- pi-Stacking: D:F.287, D:F.287
- pi-Cation interactions: D:H.258, D:H.258
NAD.12: 14 residues within 4Å:- Chain F: H.258, D.279, S.280, S.281, F.287, N.308, R.327, G.329, M.330, D.369, M.419, Q.446
- Chain H: Q.474
- Ligands: IMP.11
12 PLIP interactions:10 interactions with chain F, 2 interactions with chain H- Hydrophobic interactions: F:M.330
- Hydrogen bonds: F:D.279, F:S.281, F:N.308, F:R.327, H:Q.474, H:Q.474
- Salt bridges: F:H.258
- pi-Stacking: F:F.287, F:F.287
- pi-Cation interactions: F:H.258, F:H.258
NAD.16: 14 residues within 4Å:- Chain B: Q.474
- Chain H: H.258, D.279, S.280, S.281, F.287, N.308, R.327, G.329, M.330, D.369, M.419, Q.446
- Ligands: IMP.15
12 PLIP interactions:10 interactions with chain H, 2 interactions with chain B- Hydrophobic interactions: H:M.330
- Hydrogen bonds: H:D.279, H:S.281, H:N.308, H:R.327, B:Q.474, B:Q.474
- Salt bridges: H:H.258
- pi-Stacking: H:F.287, H:F.287
- pi-Cation interactions: H:H.258, H:H.258
NAD.20: 14 residues within 4Å:- Chain J: H.258, D.279, S.280, S.281, F.287, N.308, R.327, G.329, M.330, D.369, M.419, Q.446
- Chain L: Q.474
- Ligands: IMP.19
12 PLIP interactions:2 interactions with chain L, 10 interactions with chain J- Hydrogen bonds: L:Q.474, L:Q.474, J:D.279, J:S.281, J:N.308, J:R.327
- Hydrophobic interactions: J:M.330
- Salt bridges: J:H.258
- pi-Stacking: J:F.287, J:F.287
- pi-Cation interactions: J:H.258, J:H.258
NAD.24: 14 residues within 4Å:- Chain L: H.258, D.279, S.280, S.281, F.287, N.308, R.327, G.329, M.330, D.369, M.419, Q.446
- Chain N: Q.474
- Ligands: IMP.23
12 PLIP interactions:10 interactions with chain L, 2 interactions with chain N- Hydrophobic interactions: L:M.330
- Hydrogen bonds: L:D.279, L:S.281, L:N.308, L:R.327, N:Q.474, N:Q.474
- Salt bridges: L:H.258
- pi-Stacking: L:F.287, L:F.287
- pi-Cation interactions: L:H.258, L:H.258
NAD.28: 14 residues within 4Å:- Chain N: H.258, D.279, S.280, S.281, F.287, N.308, R.327, G.329, M.330, D.369, M.419, Q.446
- Chain P: Q.474
- Ligands: IMP.27
12 PLIP interactions:10 interactions with chain N, 2 interactions with chain P- Hydrophobic interactions: N:M.330
- Hydrogen bonds: N:D.279, N:S.281, N:N.308, N:R.327, P:Q.474, P:Q.474
- Salt bridges: N:H.258
- pi-Stacking: N:F.287, N:F.287
- pi-Cation interactions: N:H.258, N:H.258
NAD.32: 14 residues within 4Å:- Chain J: Q.474
- Chain P: H.258, D.279, S.280, S.281, F.287, N.308, R.327, G.329, M.330, D.369, M.419, Q.446
- Ligands: IMP.31
12 PLIP interactions:10 interactions with chain P, 2 interactions with chain J- Hydrophobic interactions: P:M.330
- Hydrogen bonds: P:D.279, P:S.281, P:N.308, P:R.327, J:Q.474, J:Q.474
- Salt bridges: P:H.258
- pi-Stacking: P:F.287, P:F.287
- pi-Cation interactions: P:H.258, P:H.258
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Johnson, M.C. et al., Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation. Elife (2020)
- Release Date
- 2020-03-25
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
IB
AC
JD
BE
KF
CG
LH
DI
MJ
EK
NL
FM
ON
GO
PP
H
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-16-mer
- Ligands
- 16 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Covalent)(Non-covalent)
- 8 x IMP: INOSINIC ACID(Covalent)
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Johnson, M.C. et al., Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation. Elife (2020)
- Release Date
- 2020-03-25
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
IB
AC
JD
BE
KF
CG
LH
DI
MJ
EK
NL
FM
ON
GO
PP
H